Cartesian Therapeutics (RNAC) Shares Issued (2016 - 2025)
Historic Shares Issued for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to $5000.0.
- Cartesian Therapeutics' Shares Issued fell 9999.59% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $273000.0, marking a year-over-year decrease of 9978.06%. This contributed to the annual value of $124.4 million for FY2024, which is 5376926.41% up from last year.
- As of Q3 2025, Cartesian Therapeutics' Shares Issued stood at $5000.0, which was down 9999.59% from $85000.0 recorded in Q2 2025.
- In the past 5 years, Cartesian Therapeutics' Shares Issued registered a high of $121.6 million during Q3 2024, and its lowest value of -$20.3 million during Q2 2021.
- Its 5-year average for Shares Issued is $11.6 million, with a median of $115500.0 in 2021.
- Its Shares Issued has fluctuated over the past 5 years, first crashed by 214006.02% in 2021, then surged by 14814512.2% in 2024.
- Cartesian Therapeutics' Shares Issued (Quarter) stood at $104000.0 in 2021, then crashed by 129.81% to -$31000.0 in 2022, then surged by 364.52% to $82000.0 in 2023, then skyrocketed by 148145.12% to $121.6 million in 2024, then crashed by 100.0% to $5000.0 in 2025.
- Its Shares Issued stands at $5000.0 for Q3 2025, versus $85000.0 for Q2 2025 and $183000.0 for Q1 2025.